Farmak International

⚙️ There’s a rhythm to pharmaceutical production when everything is in motion. Vials moving through the line. Pre-filled syringes in production. Quality control keeping a close eye on every stage. Beyond the line, R&D and technology transfer are advancing the next products and delivery systems. That rhythm is part of everyday work at ICM Farmak in Spain, supporting Farmak International’s growing expertise in specialized sterile products — from critical hospital medicines to long-acting injectables and advanced delivery systems. A brief glimpse of a process that rarely stands still.

⚙️ Complexity is built, not claimed. And building it carries responsibility. At Farmak International, 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗚𝗲𝗻𝗲𝗿𝗶𝗰𝘀 represent a core focus within our international portfolio strategy. These segments require integrated capabilities across development, manufacturing, and regulatory planning — aligned from the outset and sustained over time. Our focus spans hospital-relevant and high-barrier therapeutic areas, including: ✔ Iron therapies ✔ Metabolic & Endocrine ✔ Oncology & Immunology ✔ Psychiatry ✔ Ophthalmology Operating in Complex Generics means establishing structured processes, scalable EU-GMP manufacturing, and regulatory depth across markets with continuity of supply as a priority. For partners, this translates into operational reliability, portfolio resilience, and long-term collaboration built for international growth. And it remains a central pillar of how we build for the future. 🔗 Explore our Complex Generics portfolio further on our website (𝘧𝘰𝘳 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘰𝘯𝘭𝘺): https://lnkd.in/dguDTBKi

💉 Medicines used in controlled clinical settings follow a different path. This shapes how they are approached across the value chain. At Farmak International, 𝐀𝐧𝐚𝐞𝐬𝐭𝐡𝐞𝐬𝐢𝐨𝐥𝐨𝐠𝐲 & 𝐈𝐧𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐂𝐚𝐫𝐞 is a key portfolio area, reflecting our focus on medicines used in acute, closely monitored clinical settings. Working in these segments means aligning development, manufacturing, and regulatory planning from the start and maintaining that alignment over time. Our focus includes hospital-relevant therapeutic areas such as: ✔ Vasoactive agents ✔ Anaesthetics & sedatives ✔ Obstetric agents ✔ Anticoagulants This is reflected in how we structure our processes, support EU-GMP manufacturing, and plan for continuity of supply across markets. For partners, this supports reliable access, operational consistency, and long-term supply collaboration. It remains an important part of how we build and manage our international portfolio. 🔗 Explore our Anaesthesiology & Intensive Care portfolio further on our website (𝘧𝘰𝘳 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘰𝘯𝘭𝘺): https://bit.ly/4m3CzEC

In pharma, some portfolios are built around opportunity. Others are built around responsibility. At Farmak International, our portfolio reflects deliberate choices about where we operate — and what it takes to operate there consistently. 💉 Our priority focus includes: ✔️ Complex generics ✔️ Anaesthesiology & intensive care ✔️ MRI & CT These segments can only be sustained by organisations that are comfortable with complexity, regulatory depth, and long-term portfolio stewardship — not just individual launches. This perspective shapes how Farmak International builds and evolves its portfolio internationally. 🔗 https://lnkd.in/dguDTBKi (𝘧𝘰𝘳 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘰𝘯𝘭𝘺)

From dossier to production — one integrated system. At Farmak International, sterile injectables are managed as a continuous process: from development through to commercial supply. 🔬 Dossier development is handled internally, enabling faster adaptation to local requirements and reducing external dependencies. ⚙️ Development, scale-up, and manufacturing are aligned within one workflow, supporting smoother transitions to commercial production. 📦 Dedicated injectables capacity across formats allows more structured and predictable supply planning. 🔄 Processes are designed and maintained within the same system, ensuring consistency across batches and lifecycle stages. For partners, this means clearer ownership and more predictable timelines from registration to launch with fewer variables along the way. ▶️ See how this system works in practice: https://lnkd.in/devFp7JK

On 23 December, the Farmak brand marks 100 years. A milestone built over decades, shaped by experience and carried forward through everyday work. Today is a moment to pause and recognise the people behind the work — past and present. 📍 More on the 100-year story: https://lnkd.in/grmppbYu